Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
We report the case of a 50-year-old woman with severe palmoplantar psoriasis who developed alopecia areata (AA) 2 months after initiating treatment with tildrakizumab (100 mg subcutaneously). The patient had no personal or familial history of autoimmune disorders, and the diagnosis of AA was confir...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
PAGEPress Publications
2026-01-01
|
| Rangatū: | Dermatology Reports |
| Ngā marau: | |
| Urunga tuihono: | https://journals.pagepress.net/dr/article/view/10240 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|